Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-080021
Filing Date
2025-06-02
Accepted
2025-06-02 07:59:29
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3528
  Complete submission text file 0000950170-25-080021.txt   5315
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEXVET BIOPHARMA PLC NATL INST, FOSTERS AVENUE, MOUNT MERRION BLACKROCK L2 00000
Business Address
McCracken Joseph S (Reporting) CIK: 0001632454 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 251013161